|[t]MBLX[/t] has been cut in half since that article was published.|
A few observations:
-- The company has not yet filed its 10-K. According to the third quarter 10-Q, Tellas, the joint-venture with Archer Daniels Midland, will start producing commercial quantities of Mirel during the second quarter of 2009. As of September 30, the company had $94.6 million in cash and short-term investments on hand, offset by $29 million in deferred revenues (advances from ADM). The company is losing about $10 million per quarter.
-- According to the analysts surveyed by Yahoo, the company will generate revenues of $24.8 million this year (up from an estimated $1.9 million in 2008) and lose $1.58 per share.
-- The decline in oil prices has removed their cost advantage.
Hoping for $4 or lower.